Detalhe da pesquisa
1.
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non-small-cell lung cancer in New Zealand.
Intern Med J
; 50(6): 716-725, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318119
2.
Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed.
J Struct Biol
; 192(3): 539-544, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522274
3.
Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity.
J Neurochem
; 135(6): 1099-112, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364854
4.
Emerging roles of metal solute carriers in cancer mechanisms and treatment.
Biopharm Drug Dispos
; 35(8): 450-62, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24889085
5.
Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients.
BMC Cancer
; 13: 495, 2013 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156389
6.
Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Clin Exp Pharmacol Physiol
; 40(6): 371-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23556474
7.
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.
BMC Cancer
; 12: 496, 2012 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23098625
8.
Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
J Pharmacol Exp Ther
; 338(2): 537-47, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21606177
9.
A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients.
BMC Cancer
; 11: 432, 2011 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982454
10.
Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
Mol Pain
; 6: 53, 2010 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20836889
11.
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
BMC Cancer
; 10: 451, 2010 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20731872
12.
ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy.
Future Oncol
; 6(10): 1537-43, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21062153
13.
Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue.
Mol Pain
; 5: 66, 2009 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19922644
14.
In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.
J Inorg Biochem
; 102(2): 303-10, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18029019
15.
Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.
Clin Exp Pharmacol Physiol
; 35(12): 1440-6, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18671714
16.
Incomplete uptake of EGFR mutation testing and its impact on estimation of mutation prevalence in patients with non-squamous NSCLC: A population-based study in New Zealand.
Cancer Epidemiol
; 57: 24-32, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30278336
17.
The Effects of Synthetically Modified Natural Compounds on ABC Transporters.
Pharmaceutics
; 10(3)2018 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096910
18.
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC.
Target Oncol
; 13(1): 89-98, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29188408
19.
Satraplatin in hormone-refractory prostate cancer and other tumour types: pharmacological properties and clinical evaluation.
Drugs
; 67(6): 859-69, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17428104
20.
Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours.
Cancer Chemother Pharmacol
; 59(5): 661-9, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16944150